This part is subdivided into five subparts. Each subpart contains information related to a broad topic or specific audience with special responsibilities as shown in the following table.
| In subpart . . .
| You will find sections related to . . .
|
|---|
| A | General information about this part.
|
| B | Definitions used in this part.
|
| C | Responsibilities of institutions with PHS support.
|
| D | Responsibilities of the U.S. Department of Health and Human Services and the Office of Research Integrity.
|
| E | Information on how to contest ORI research misconduct findings and proposed HHS administrative actions. |
This part uses terms throughout the text that have special meaning. Those terms are defined in subpart B of this part.
(a) An institution must follow this part for allegations received by the institution on or after January 1, 2026, except for the policies and procedures required under §§ 93.300(a) and 93.302(b), which must be implemented and submitted by due date of the annual report covering the 2025 reporting year, as specified by ORI.
(b) For allegations received by an institution before January 1, 2026, unless the institution and the respondent both elect in writing to follow this part, an institution must follow this part as published in the 2005 edition of the Code of Federal Regulations.